Open AccessThe minimum dose of dexmedetomidine required for cessation of postspinal anesthesia shivering: A prospective observational study
Author(s) -
Tanveer Singh Kundra,
Parminder Kaur
Publication year - 2017
Publication title -
journal of anaesthesiology-clinical pharmacology/journal of anaesthesiology clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.466
H-Index - 32
eISSN - 2231-2730
pISSN - 0970-9185
DOI - 10.4103/joacp.joacp_115_16
Subject(s) - dexmedetomidine , medicine , shivering , anesthesia , observational study , sedation
Shivering is a common postanesthesia adverse event with multiple etiologies. Dexmedetomidine, a centrally acting alpha-2 adrenergic agonist, is known to reduce the shivering threshold. However, the minimum dose at which dexmedetomidine causes cessation of shivering is unknown. The aim of this prospective observational study was to find the minimum dosage of dexmedetomidine required for abolition of post-spinal anesthesia (SA) shivering.